Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 30, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 10, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
- Aug 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record47827 flagged findings
Reported transactions (Form 4)80since Apr 1, 2024 · and 26 other holdings
Corporate events (8-K)30since Apr 29, 2022
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Identity
Formerly traded as AVTE.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-06-04share offering or dilution eventrecentOpen filing ↗“…• sell, offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open “put equivalent…”
+1 more passage from the same document
- “…common stock currently or hereafter owned either of record or beneficially; • enter into any swap, hedge or similar arrangement or…”
- 2026-06-04capital return (buybacks/dividends)recentOpen filing ↗“…members or by a corporation to its stockholders or former stockholders or to any wholly owned subsidiary of such corporation;…”
+1 more passage from the same document
- “…provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which…”
- 2026-06-04merger or acquisition eventrecentOpen filing ↗“…we announced that the first patient was dosed in our Phase 1 trial evaluating JADE201 in patients with rheumatoid arthritis.…”
+1 more passage from the same document
- “…for the benefit, of the Series A Preferred Stock, regardless of whether any of the foregoing actions will be by means of…”
- 2026-06-03share offering or dilution eventrecentOpen filing ↗“…in lieu of shares of common stock to certain investors that so choose, pre-funded warrants to purchase shares of our common stock.…”
+1 more passage from the same document
- “…pre-funded warrant will equal the price per share at which the shares of our common stock are being sold to the public in this…”
- 2026-06-03capital return (buybacks/dividends)recentOpen filing ↗“…members or by a corporation to its stockholders or former stockholders or to any wholly owned subsidiary of such corporation;…”
+1 more passage from the same document
- “…provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which…”
- 2026-06-03merger or acquisition eventrecentOpen filing ↗“…we announced that the first patient was dosed in our Phase 1 trial evaluating JADE201 in patients with rheumatoid arthritis.…”
+1 more passage from the same document
- “…for the benefit, of the Series A Preferred Stock, regardless of whether any of the foregoing actions will be by means of…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
Reverse splits in 5 years
2 reverse splits in 5 years (1:3.11 on Jun 22, 2022, 1:35 on Apr 29, 2025) · 1:109 cumulative
The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 478)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 30, 268-K ↗Current report · Other events
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Venrock Healthcare Capital Partners III, L.P. · 8.3% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Bellevue Group AG · 5.0% · event on Jun 30, 26 · amendment
- Aug 10, 2610-Q ↗Quarterly report
- Aug 10, 268-K ↗Current report · Results
- Jul 17, 26SCHEDULE 13G ↗Passive stake · Paradigm BioCapital Advisors LP · 5.1% · event on Jul 10, 26
- Jul 8, 26SCHEDULE 13G/A ↗Passive stake · JANUS HENDERSON GROUP Ltd. · 10.6% · event on Jun 30, 26 · amendment
- Jul 1, 268-K ↗Current report · Entered a material agreement
- Jun 26, 26Form 4 ↗Insider transaction
- Jun 26, 26Form 3 ↗Insider transaction
- Jun 26, 268-K ↗Current report · A senior executive left or was appointed
- Jun 11, 268-K ↗Current report · Bylaws or fiscal year change · Shareholder vote results
- Jun 9, 26SCHEDULE 13D/A ↗Stake with intent to influence · Fairmount Funds Management LLC · 20.0% · event on Jun 5, 26 · amendment
- Jun 5, 26DEFA14A ↗Shareholder meeting and votes
- Jun 4, 268-K ↗Current report · Other events
- Jun 4, 26424B5 ↗Securities offering
- Jun 3, 26424B5 ↗Securities offering
- Jun 1, 268-K ↗Current report · Communication to the market · Other events
- May 15, 26SCHEDULE 13G/A ↗Passive stake · JANUS HENDERSON GROUP PLC · 6.3% · event on Mar 31, 26 · amendment
- May 15, 26424B3 ↗Securities offering
478 filings on record, the oldest from Jun 2, 21.
Listing the 25 most recent filings of the 478 on record.
31614
- Jul 1, 26Entered a material agreement8-K 1.01 ↗
3 senior executive changes2026show all 3hide
- Jun 26, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Apr 22, 26A senior executive left or was appointed8-K 5.02 ↗
- Apr 2, 26A senior executive left or was appointed8-K 5.02 ↗
- Dec 15, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Oct 7, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Sep 9, 25A senior executive left or was appointed8-K 5.02 ↗
- Jul 1, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- May 14, 25Completed an acquisition or disposal+3 more in the same filing8-K 2.01 ↗
- May 1, 25Entered a material agreement+11 more in the same filing8-K 1.01 ↗
- Oct 31, 24Entered a material agreement+5 more in the same filing8-K 1.01 ↗
- Oct 17, 24Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Oct 10, 24A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jul 1, 24Restructuring plan with committed costs8-K/A 2.05 ↗
5 older filings not shown · The record reaches back to Jul 19, 21.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- Jun 28, 24Restructuring plan with committed costs8-K 2.05 ↗
The full record holds 3 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Fairmount Funds Management LLC20.0%Jun 5, 26SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- RA Capital Management, L.P.4.1%Apr 28, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Sofinnova Venture Partners X, L.P. ("SVP X")0.3%Apr 28, 25SCHEDULE 13D/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
- Atlas Venture Fund XII, L.P.0.2%Apr 28, 25SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- JANUS HENDERSON GROUP Ltd.10.6%Jun 30, 26SCHEDULE 13G/A ↗2 earlier filings
- Venrock Healthcare Capital Partners III, L.P.8.3%Jun 30, 26SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- RA Capital Management, L.P.7.0%Oct 8, 25SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Deep Track Capital, LP7.0%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
- Paradigm BioCapital Advisors LP5.1%Jul 10, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
show 4 more holdershide
- Bellevue Group AG5.0%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- BlackRock, Inc.4.7%Mar 31, 26SCHEDULE 13G/A ↗1 earlier filing
- The Vanguard Group4.2%Dec 31, 25SCHEDULE 13G/A ↗
- Frazier Life Sciences Public Fund, L.P.4.2%Sep 30, 25SCHEDULE 13G/A ↗11 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- May 16, 25Buy$44KTom FrohlichChief Executive Officer↗
- Jun 17, 24Buy$1.5MRA CAPITAL MANAGEMENT, L.P.↗
- Jun 14, 24Sell$265KMarinus VerwijsCHIEF TECHNICAL OFFICER↗
- Jun 14, 24Sell$375KGeorge A EldridgeSEE REMARKS↗
- Jun 13, 24Sell$147KHunter GilliesCHIEF MEDICAL OFFICER↗
- May 17, 24Sell$82KHunter GilliesCHIEF MEDICAL OFFICER↗
- May 17, 24Sell$2KHunter GilliesCHIEF MEDICAL OFFICER↗
- May 16, 24Sell$187KTIMOTHY P NOYESCHIEF EXECUTIVE OFFICER↗
- May 16, 24Sell$28KTIMOTHY P NOYESCHIEF EXECUTIVE OFFICER↗
- May 2, 24Sell$42KMarinus VerwijsCHIEF TECHNICAL OFFICER↗
- May 1, 24Sell$184KTIMOTHY P NOYESCHIEF EXECUTIVE OFFICER↗
- May 1, 24Sell$20KTIMOTHY P NOYESCHIEF EXECUTIVE OFFICER↗
There are 10 more transactions in this stretch.
Stock compensation, tax and giftsshow the 18 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Feb 12, 26Compensationamount n/aAndrew James KingSee Remarks↗
- Feb 12, 26Compensationamount n/aTom FrohlichChief Executive Officer↗
- Feb 12, 26Compensationamount n/aElizabeth BaltaSee Remarks↗
- Feb 12, 26Compensationamount n/aBradford D. DahmsChief Financial Officer↗
- Oct 6, 25Compensation$12.2MFairmount Funds Management LLC↗
- Apr 28, 25Otheramount n/aRA CAPITAL MANAGEMENT, L.P.↗
- Aug 1, 24Compensation$3KBenjamin T DakeSEE REMARKS↗
- Jul 31, 24Compensation$20KBenjamin T DakeSEE REMARKS↗
- Jun 14, 24Compensation$155KMarinus VerwijsCHIEF TECHNICAL OFFICER↗
- Jun 14, 24Compensation$32KGeorge A EldridgeSEE REMARKS↗
- Jun 13, 24Compensation$13KHunter GilliesCHIEF MEDICAL OFFICER↗
- May 17, 24Compensation$9KHunter GilliesCHIEF MEDICAL OFFICER↗
- May 16, 24Compensation$21KTIMOTHY P NOYESCHIEF EXECUTIVE OFFICER↗
- May 1, 24Compensation$21KTIMOTHY P NOYESCHIEF EXECUTIVE OFFICER↗
- Apr 17, 24Compensation$7KHunter GilliesCHIEF MEDICAL OFFICER↗
- Apr 17, 24Compensation$15KBenjamin T DakeSEE REMARKS↗
- Apr 16, 24Compensation$21KTIMOTHY P NOYESCHIEF EXECUTIVE OFFICER↗
- Apr 10, 24Compensation$16KGeorge A EldridgeSEE REMARKS↗
The full record holds 217 transactions and goes back to Jan 3, 23.
Its sector and its market
Jade Biosciences Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Jade Biosciences Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Jade Biosciences Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 478 documents on file, from Jun 2, 2021 to Sep 30, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.